Greykasell Wealth Strategies, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2041220
DANVILLE, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$298,052
-$71,269 QoQ
Shares Held
478
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#949
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Greykasell Wealth Strategies, Inc. holds $320,635 across 3 Biotechnology names. REGN ranks #1 (93.0% of the industry book) .
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,052 | 478 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $369,321 | 478 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $368,953 | 478 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $205,228 | 365 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $209,475 | 399 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $449,034 | 708 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $504,329 | 708 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||